Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹8114 Cr | ₹1296 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹500 | ₹100 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 05 Jun 2004 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare | Nifty Pharma TRI |
| Turn Over | 21% | 26.49% |
| Expense Ratio | 1.82 | 2.14 |
| Manager | Sailesh Raj Bhan | Meeta Shetty |
| ISIN Code | INF204K01968 | INF277K016A9 |
| Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | 2.16% | 1.62% |
| 6 Month | 3.03% | 4.67% |
| 1 Year | -0.53% | 0.03% |
| 3 Year | 20.87% | 21.54% |
| 5 Year | 18.19% | 18.03% |
SIP Return Analysis
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -0.19% | 1.96% |
| 1 Year | 5.08% | 8.61% |
| 3 Year | 18.94% | 20.94% |
| 5 Year | 17.4% | 18.6% |
Rolling Lumpsum Returns
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 16.99% | 9.76% |
| 3 Year | 20.8% | 18.6% |
| 5 Year | 20.54% | 15.32% |
Risk Management
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | 15.22% | 16.05% |
| Sharp | 0.89% | 0.90% |
| Beta | 0.91% | 0.98% |
| Alpha | -0.46% | -0.49% |
Fund Managers
| Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Sailesh Raj Bhan | Meeta Shetty |
| Total AUM | ₹96086 Cr | ₹17847 Cr |
| Funds Managed | 5 | 5 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.52 | 4.14 |
| Large Cap | 33.27 | 25.14 |
| Mid Cap | 33.86 | 37.44 |
| Small Cap | 31.35 | 33.28 |
Sector Allocation
| Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 0.53 | 1.72 |
| Healthcare | 99.47 | 94.07 |
| Basic Materials | - | 2.64 |
| Financial Services | - | 1.58 |
Top Comparisons
SBI Healthcare Opportunities Fund - Regular Plan -Growth
3Y Returns24.41%
Mirae Asset Healthcare Fund -Regular Growth
3Y Returns20.42%
BANDHAN Bond Fund - Short Term - Regular Plan - Growth
3Y Returns7.65%
DSP Short Term Fund - Regular Plan - Growth
3Y Returns7.36%
SBI Arbitrage Opportunities Fund - Regular Plan - Gr
3Y Returns7.17%
Tata Arbitrage Fund-Regular Plan-Growth
3Y Returns6.96%
Tata Value Fund - Regular Plan - Growth Option
3Y Returns19.27%
Axis Value Fund - Regular Plan - Growth
3Y Returns22.94%